Cresco Labs submitted a new filing last week, urging an Illinois federal court to dismiss a proposed consumer class action alleging the company mislabeled certain cannabis vape oils to circumvent state THC potency limits. In its latest filing, the company argued that the lawsuit suffers from “fundamental flaws,” emphasizing that no consumer has claimed to have been harmed by purchasing the products at issue.
The suit alleges Cresco improperly classified some cannabis oils as concentrates rather than cannabis-infused products, a distinction that carries different THC caps and labeling requirements under Illinois law. Cresco disputes this characterization, saying its products complied with state regulations and that disputes over classification and labeling fall under the authority of regulators, not private plaintiffs.

